Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-068364

Chief Financial Officer acquired 1,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2023-12-01 Grant or award +508 $25.97 $13,193 8,437 D
Mokari Atabak Chief Financial Officer 2023-12-01 Grant or award +508 8,945 D
Loading xslF345X05/ownership.xml…